Beta Bionics Inc (NAS:BBNX)

Q4 2025 Beta Bionics Inc Earnings Call Transcript

Feb 17, 2026 / 09:30 PM GMT

Release Date Price: $13.97 (+0.22%)

Transcript 10-K8-K

Key Points

Positve

Beta Bionics Inc (BBNX) achieved $100.3 million in net sales for 2025, marking a 54% year-over-year growth.
The company doubled its user base in 2025, with close to 20,000 new users adopting their technology.
Gross margin expanded to 55.4% for the full year, with Q4 gross margin reaching 59%, driven by increased scale and manufacturing volume.
Beta Bionics Inc (BBNX) established formulary agreements with all major pharmacy benefit managers in the US, enhancing access to their products.
The company made significant progress in R&D, including the development of their patch pump program, Mint, and completed their first clinical trials for their bi-hormonal system.

Negative

The company received a warning letter from the FDA related to their complaint handling system and other quality system issues.
Operating expenses increased by 42% in Q4 2025 compared to the previous year, driven by sales force expansion and R&D costs.
There is a potential short-term revenue headwind due to the pharmacy channel strategy, which involves giving away the islet for free initially.
The company anticipates a sequential decline in Q1 2026 revenue due to seasonality and deductible resets.
Beta Bionics Inc (BBNX) will no longer provide exact quarterly new patient start figures, which may reduce transparency for investors.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

BBNX.OQ - Beta Bionics Inc
Q4 2025 Beta Bionics Inc Earnings Call
Feb 17, 2026 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day and thank you for standing by.

Welcome to the Beta Bionics Inc Q4 and full year 2025 earnings conference call and webcast.

At this time, all participants are not listen-only mode.

Please be advised that today's conference is being recorded.

After the speaker's presentation, there will be a question-and-answer session.

To ask a question, please press 11 on your telephone and wait for your name to be announced.

To withdraw your question, please press 11 again.

I would not like to hand the conference over to your speaker today.

Blake Beaver, head of investor relations.

Good afternoon and thank you for tuning in to Beta Bionics 4th quarter and full

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.